JPD
13 FDA 510(k) clearances · Product code
69 daysmedian time to decision
141 days90th percentile
13clearances measured
FDA profile
- Official device name
- Hemoglobin A2 Quantitation
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 864.7400
- Medical specialty
- Hematology
- Flags
- Third-party review eligible
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| G7 AUTOMATED HPLC ANALYZER, BETA-THALASSEMIA MODE (K020489) | Tosoh Medics, Inc. | 2002-05-14 |
| VARIANT II B-THALASSEMIA (K991127) | Bio-Rad | 1999-06-10 |
| VARIANT BETA-THALASSEMIA SHORT PROGRAM (K924122) | Bio-Rad | 1993-03-11 |
| GLYCOMAT GREEN HBA2 ESTIMATION REAGENT KIT (K924496) | Drew Scientific , Ltd. | 1992-11-16 |
| COLUMNMATE BETA THAL HBA2 CONTROL-ABNORMAL (K923317) | Helena Laboratories | 1992-08-25 |
| COLUMNMATE BETA-THAL HBA2 CONTROL - NORMAL (K923318) | Helena Laboratories | 1992-08-25 |
| COLUMNMATE(TM) BETA-THAL CAT. NO. 4515 (K913384) | Helena Laboratories | 1991-12-17 |
| HEMOGLOBIN A2 MICRO COLUMN TEST (K896168) | Bio-Rad | 1990-01-18 |
| DETER. OF HEMOGLOBIN A2 USING THE DIAMAT (K875102) | Bio-Rad | 1988-02-24 |
| BETA THALQUIK COLUMN #5341 (K823870) | Helena Laboratories | 1983-02-01 |
| HELENA SICKLE-THAL QUIK COLUMN METHOD (K812077) | Helena Laboratories | 1981-08-18 |
| HELENA HBA2 QUIK COLUMN METHOD (K803108) | Helena Laboratories | 1981-01-09 |
| HEMOHLOBIN A2 CONTROL-LYOPHILIZED (K801410) | Isolab, Inc. | 1980-07-21 |
Track JPD automatically
Every clearance here is in the API, with alerts when new ones post.